Comment from Advancing American Freedom Foundation

Summary: The Advancing American Freedom Foundation opposes the petition by the Attorney General of Massachusetts, arguing that the FDA should not lift Risk Evaluation and Mitigation Strategies (REMS) for mifepristone. The organization urges the FDA to reinstate stricter regulations, including in-person consultations, citing studies that suggest the drug poses significant health risks to women.